Spirosure Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Investors
-
1
Spirosure General Information
Description
Manufacturer of breath-based diagnostic and monitoring devices intended for novel breath-based analysis in disease diagnosis and management. The company specializes in the development and commercialization of breath-analysis devices that are used for the management of chronic diseases, such as asthma, cystic fibrosis, and chronic pulmonary hypertension, and monitor adherence to asthma-maintenance medication use, thereby enabling medical researchers to detect biomarkers in patient's breath to diagnose and monitor respiratory conditions.
Contact Information
Website
spirosure.comCorporate Office
- 7020 Koll Center Parkway
- Suite 110
- Pleasanton, CA 94566-3107
- United States
Corporate Office
- 7020 Koll Center Parkway
- Suite 110
- Pleasanton, CA 94566-3107
- United States
Spirosure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 03-Jun-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C2) | 31-Jan-2018 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 30-Jun-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 07-Nov-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC | Completed | Generating Revenue | ||||
| 1. University Spin-Out | 01-Jan-2011 | Completed | Startup |
Spirosure Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Seed 3 | ||||||||
| Seed 2 | 2,631,578 | $0.001000 | $0.03 | $0.38 | $0.38 | 1x | $0.38 | 3.15% |
| Seed 1 | 3,942,306 | $0.001000 | $0.02 | $0.26 | $0.26 | 1x | $0.26 | 4.71% |
Spirosure Comparisons
Industry
Financing
Details
Spirosure Competitors (7)
One of Spirosure’s 7 competitors is Fischer ANalysen Instrumente, a Private Equity-Backed company based in Leipzig, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fischer ANalysen Instrumente | Private Equity-Backed | Leipzig, Germany | ||||
| Breath Diagnostics | Venture Capital-Backed | Louisville, KY | ||||
| Owlstone Medical | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Omron Healthcare | Formerly VC-backed | Lake Forest, IL | ||||
| Masimo | Formerly PE-Backed | Irvine, CA |
Spirosure Patents
Spirosure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019018121-A1 | Apparatus and method for offline collection of breath samples for nitric oxide measurement | Inactive | 17-Jul-2017 | ||
| US-20180348155-A1 | Gas detection apparatus | Inactive | 02-Jun-2017 | ||
| WO-2018222803-A1 | Gas detection apparatus | Inactive | 02-Jun-2017 | ||
| WO-2018183215-A1 | Combined sensor apparatus for breath gas analysis | Inactive | 27-Mar-2017 | ||
| WO-2018183204-A1 | Hyperglycemic sensor apparatus for breath gas analysis | Inactive | 27-Mar-2017 | G01N33/497 |
Spirosure Signals
Spirosure Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Carmen Innovation | Venture Capital | Minority | ||
| Fosun International | Limited Partner | Minority | ||
| Angel (individual) | Minority | |||
| Iconical | Venture Capital | Minority | ||
| Niterra | Corporation | Minority |
Spirosure FAQs
-
When was Spirosure founded?
Spirosure was founded in 2011.
-
Where is Spirosure headquartered?
Spirosure is headquartered in Pleasanton, CA.
-
What is the size of Spirosure?
Spirosure has 10 total employees.
-
What industry is Spirosure in?
Spirosure’s primary industry is Diagnostic Equipment.
-
Is Spirosure a private or public company?
Spirosure is a Private company.
-
What is Spirosure’s current revenue?
The current revenue for Spirosure is .
-
How much funding has Spirosure raised over time?
Spirosure has raised $41M.
-
Who are Spirosure’s investors?
Carmen Innovation, Fosun International, , Iconical, and Niterra are 5 of 10 investors who have invested in Spirosure.
-
Who are Spirosure’s competitors?
Fischer ANalysen Instrumente, Breath Diagnostics, Owlstone Medical, Omron Healthcare, and Masimo are some of the 7 competitors of Spirosure.
-
When was Spirosure acquired?
Spirosure was acquired on 03-Jun-2020.
-
Who acquired Spirosure?
Spirosure was acquired by CAIRE (Georgia).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process